Clinical Trials Logo

Clinical Trial Summary

The objective of this protocol is to use established standard criteria and methods for the collection of hMSC (human mesenchymal stromal cells) from healthy bone marrow donors. The hMSC collected from the donors will use to develop well-defined and reproducible cell banks. Standard manufacturing procedures and quality control testing methods will be used to characterize and evaluate the final cell product. After the cell banks are created, these cell products will be used in future translational or clinical research.


Clinical Trial Description

Cell banks will be manufactured and cellular products used for future translational or clinical research. ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT01463475
Study type Interventional
Source University of Wisconsin, Madison
Contact
Status Completed
Phase N/A
Start date September 2011
Completion date December 2013

See also
  Status Clinical Trial Phase
Completed NCT02290080 - Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers Phase 3
Completed NCT00211172 - HMO Research Network CERT: Acute Myocardial Infarction N/A
Completed NCT03725826 - Risk Stratification After Acute Myocardial Infarction With Cardiac MRI
Not yet recruiting NCT06118281 - ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack Phase 3
Completed NCT02804906 - Rehabilitation in the Home Setting for Older Adults In the Early Period After Myocardial Infarction N/A
Completed NCT01890018 - Partners and Alerts: A Study of Social Forces in Medication Adherence N/A
Completed NCT05696379 - Angiography Derived Index of Microcirculatory Resistance in Patients With Acute Myocardial Infarction
Recruiting NCT02018497 - Essential Hypotension and Allostasis Registry
Completed NCT00833612 - Counterpulsation Reduces Infarct Size Pre-PCI for AMI Phase 4
Completed NCT00781118 - AngelMed for Early Recognition and Treatment of STEMI Phase 3
Not yet recruiting NCT04835207 - Metabolic Profile as a Predictor of No-reflow in Diabetic Patients